New tool is major milestone against lethal condition, TAU researchers say
Antimicrobial resistance is one of the biggest threats to global health, affecting anyone, at any age, in any country, according to the World Health Organization. Currently, 700,000 deaths each year are attributed to antimicrobial resistance, a figure which could increase to 10 million a year by 2050 save further intervention.
New breakthrough technology from Tel Aviv University facilitates DNA delivery into drug-resistant bacterial pathogens, enabling their manipulation. The research expands the range of bacteriophages, which are the primary tool for introducing DNA into pathogenic bacteria to neutralize their lethal activity. A single type of bacteriophage can be adapted to a wide range of bacteria, an innovation which will likely accelerate the development of potential drugs based on this principle.
Prof. Udi Qimron of the Department of Clinical Microbiology and Immunology at TAU’s Sackler Faculty of Medicine led the research team, which also included Dr. Ido Yosef, Dr. Moran Goren, Rea Globus and Shahar Molshanski, all of Prof. Qimron’s lab. The study was recently published in Molecular Cell and featured on its cover.
For the research, the team genetically engineered bacteriophages to contain the desired DNA rather than their own genome. They also designed combinations of nanoparticles from different bacteriophages, resulting in hybrids that are able to recognize new bacteria, including pathogenic bacteria. The researchers further used directed evolution to select hybrid particles able to transfer DNA with optimal efficiency.
“DNA manipulation of pathogens includes sensitization to antibiotics, killing of pathogens, disabling pathogens’ virulence factors and more,” Prof. Qimron said. “We’ve developed a technology that significantly expands DNA delivery into bacterial pathogens. This may indeed be a milestone, because it opens up many opportunities for DNA manipulations of bacteria that were impossible to accomplish before.
“This could pave the way to changing the human microbiome — the combined genetic material of the microorganisms in humans — by replacing virulent bacteria with a-virulent bacteria and replacing antibiotic-resistant bacteria with antibiotic-sensitive bacteria, as well as changing environmental pathogens,” Prof. Qimron continued.
“We have applied for a patent on this technology and are developing products that would use this technology to deliver DNA into bacterial pathogens, rendering them a-virulent and sensitive to antibiotics,” Prof. Qimron said.
The Latest on: Antimicrobial resistance
- Antimicrobial effectiveness leaning to 'tipping point' resistance, says FAOon November 25, 2021 at 4:45 pm
We may soon reach “a tipping point” when antimicrobial resistance (AMR) becomes the leading cause of death – surpassing heart disease ...
- Key step in how bacteria acquire drug resistance revealedon November 25, 2021 at 7:44 am
Researchers have imaged a major component in conjugation—the process bacteria use to share DNA with each other.
- Africa: Antimicrobial Effectiveness Leaning to 'Tipping Point' Resistance - FAOon November 24, 2021 at 11:23 pm
We may soon reach "a tipping point" when antimicrobial resistance (AMR) becomes the leading cause of death - surpassing heart disease and other so-called lifestyle illnesses, the Food and Agricultural ...
- Poor disposal of antibiotics used in poultry and pig farms contribute to antimicrobial resistance – KATHon November 24, 2021 at 5:32 pm
The Komfo Anokye Teaching Hospital is attributing the surging cases of antimicrobial resistance development and spread to the use of antibiotics in pig and poultry farms.
- Trump's surgeon general: US needs to fight antimicrobial resistance to prevent next pandemicon November 24, 2021 at 11:44 am
Dr. Jerome Adams, who served as U.S. surgeon general under former President Trump, is calling for action to combat the threat of antimicrobial resistance.
- With antibiotic resistance, 'we are running out of options'on November 24, 2021 at 6:33 am
Experts predict that without intervention, the problem of multidrug-resistant bacterial infections could be catastrophic by 2050, killing nearly 10 million people each year.
- Hepatitis C drug may reduce antibiotic resistance, researchers sayon November 23, 2021 at 1:13 pm
A hepatitis C drug, telaprevir, can block the function of essential proteins in bacteria, which may allow to it be repurposed to limit antibiotic resistance, a study released Tuesday showed.
- Antimicrobial Resistance: The Silent Pandemicon November 23, 2021 at 8:29 am
We are on the precipice of a looming crisis. Antimicrobial resistance (AMR) is the evolution of deadly pathogens like bacteria and fungi to resist all current antimicrobial medicines. In this episode, ...
- Targeting antimicrobial resistanceon November 22, 2021 at 2:29 am
Funding for early-stage projects and global collaborations are aiming to breathe life into the fragile ecosystem for novel antibiotics.
- Voices: Antibiotic resistance is a ticking time bomb – our pill popping has to stopon November 20, 2021 at 4:56 am
Imagine a world where common bacterial infections like an infected wound, strep throat or diseases such as tuberculosis or are no longer treatable ...
via Google News and Bing News